Business & Finance

Biopharma company announced financial results

Published in Biotech Business Week, August 8th, 2005

Peregrine Pharmaceuticals, Inc., (PPHM) announced its financial results for the year ended April 30, 2005, and its operational highlights.

Revenues generated by Avid Bioservices, Inc., the company's wholly owned subsidiary, increased $1,645,000 (or 54%) to $4,684,000 compared to $3,039,000 for the prior year. This increase in revenues helped offset the company's consolidated net loss of $15,452,000, or $0.11 per basic and diluted share, compared to a net loss of $14,345,000, or $0.11 per basic and diluted share, for the prior year ended April 30, 2004.

Total revenues for the year increased to $4,959,000 compared to $3,314,000 in fiscal year 2004, an...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-08-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry